In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales
ACS Infectious Diseases · 2023
DOI: 10.1021/acsinfecdis.2c00485 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Byron K Peters und 16 weiteren Autor:innen. Beteiligte Einrichtung: Catalysis and Peptide Research Unit, University of KwaZulu Natal, Durban 4001, South Africa. Hauptthemen laut MEDLINE: Carbapenems, beta-Lactamase Inhibitors. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Inyuvesi Yakwazulu-Natali, National Research Foundation, Technology Innovation Agency of South Africa.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Catalysis and Peptide Research Unit, University of KwaZulu Natal, Durban 4001, South Africa.
- School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng 2193, South Africa.
- School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4041, South Africa.
- Biomedical Research Unit, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
- Department of Pharmaceutical Science, University of KwaZulu-Natal, Westville Campus, Durban 3629, South Africa.
- Science for Life Laboratory, Drug Discovery & Development Platform & Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sw…
ORCID-Profile: Byron K Peters, Anil Chuturgoon, Hendrik G Kruger, Tricia Naicker, Thavendran Govender
Förderung
- Inyuvesi Yakwazulu-Natali
- National Research Foundation
- Technology Innovation Agency of South Africa
Zitieren
APA
Peters, B. K., Reddy, N., Shungube, M., Girdhari, L., Baijnath, S., Mdanda, S., Chetty, L., Ntombela, T., Arumugam, T., Bester, L. A., Singh, S. D., Chuturgoon, A., Arvidsson, P. I., Maguire, G. E. M., Kruger, H. G., Naicker, T., & Govender, T. (2023). In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.2c00485
Vancouver
Peters BK, Reddy N, Shungube M, Girdhari L, Baijnath S, Mdanda S, et al. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.2c00485
BibTeX
@article{Peters2023,
author = {Peters, Byron K and Reddy, Nakita and Shungube, Mbongeni and Girdhari, Letisha and Baijnath, Sooraj and Mdanda, Sipho and Chetty, Lloyd and Ntombela, Thandokuhle and Arumugam, Thilona and Bester, Linda A and Singh, Sanil D and Chuturgoon, Anil and Arvidsson, Per I and Maguire, Glenn E M and Kruger, Hendrik G and Naicker, Tricia and Govender, Thavendran},
title = {In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales},
journal = {ACS Infectious Diseases},
year = {2023},
doi = {10.1021/acsinfecdis.2c00485}
}
EUVIMED